Related Experiment Video
Updated: Jul 15, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
New targets for obesity pharmacotherapy
L J Aronne1, Z D Thornton-Jones
1Weill Medical College of Cornell University, New York, New York, USA. ljaronne@med.cornell.edu
Clinical Pharmacology and Therapeutics
|April 18, 2007
Summary
Understanding how the body regulates energy balance is key to developing new obesity treatments. Signals from fat stores and fullness inform the brain, influencing eating habits and energy use for weight management.
Area of Science:
- Physiology
- Metabolism
- Neuroscience
Background:
- Energy homeostasis is crucial for maintaining body weight.
- Adiposity and satiety signals communicate energy reserve status to the brain.
- These signals regulate food intake and energy expenditure.
Purpose of the Study:
- To review the mechanisms regulating energy homeostasis.
- To discuss the role of adiposity and satiety signals in energy balance.
- To highlight the development of novel antiobesity therapies targeting these regulatory networks.
Main Methods:
- Review of existing literature on energy homeostasis.
- Analysis of signaling pathways involved in appetite regulation.
- Examination of current and emerging antiobesity therapeutic strategies.
Main Results:
- Energy homeostasis is regulated by complex signaling between peripheral tissues and the brain.
- Adiposity and satiety signals are critical mediators of energy balance.
- Targeting anabolic or catabolic pathways offers promising avenues for obesity treatment.
Conclusions:
- A thorough understanding of energy homeostasis mechanisms is essential for effective obesity therapy development.
- Novel antiobesity therapies aim to modulate food intake and energy expenditure.
- Future research should focus on refining these targeted approaches for sustainable weight loss.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...